The major finding of this study is that the EZH2 knockdown significantly suppressed the formation of tumor spheroids in vitro (a characteristic of IBC cancer stem cells), and tumor growth in vivo in a new human IBC model. Here, EZH2 is linked to inflammatory breast carcinoma.